Tiger BioSciences announced the publication of interim data from the ongoing TIGERCAMP randomized controlled trial (RCT), now ...
Two replicate phase 3 randomized controlled trials involving patients with chronic hepatitis B virus (HBV) infection demonstrate a functional cure after the discontinuation of conventional long-term ...
A new study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial ...
Morning Overview on MSN
A 40-year pillar of heart attack care just crumbled — a massive international trial found the beta blockers millions take after a heart attack offered no real benefit
For roughly four decades, the playbook after a heart attack has included a near-automatic prescription: beta-blockers, taken ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer Newly diagnosed patients with cT2-4N0-2M0 HNC were ...
Morning Overview on MSN
A massive long-term review just tied GLP-1 weight-loss drugs to sharply lower rates of heart attacks, strokes, heart failure, and early death
When the results of the SELECT trial landed in the New England Journal of Medicine in November 2023, they confirmed what ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results